LRMR
Larimar Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.93
+0.10 (+2.61%)
Rating:C+
Company Profile
CEO
Carole S. Ben-Maimon
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.82
Prev. Close
$3.83
Day Low
$3.74
Day High
$3.98
52W Low
$2.71
52W High
$6.42
Market Cap
$0.34B
Volume
0.97M